Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank 2014 BioFEST

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs primarily in the infectious disease field, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in a fireside chat, or question and answer session, with investors December 1, 2014 at 10:25 a.m. ET during the Deutsche Bank 2014 BioFEST conference in Boston.

Help employers find you! Check out all the jobs and post your resume.

Back to news